[HTML][HTML] Serum miRNA profiling for early PDAC diagnosis and prognosis: a retrospective study
A Aita, C Millino, C Sperti, B Pacchioni, M Plebani… - Biomedicines, 2021 - mdpi.com
Background: Tumor stage predicts pancreatic cancer (PDAC) prognosis, but prolonged and
short survivals have been described in patients with early-stage tumors. Circulating
microRNA (miRNA) are an emerging class of suitable biomarkers for PDAC prognosis. Our
aim was to identify whether serum miRNA signatures predict survival of early-stage PDAC.
Methods: Serum RNA from archival 15 stage I-III PDAC patients and 4 controls was used for
miRNAs expression profile (Agilent microarrays). PDAC patients with comparable age …
short survivals have been described in patients with early-stage tumors. Circulating
microRNA (miRNA) are an emerging class of suitable biomarkers for PDAC prognosis. Our
aim was to identify whether serum miRNA signatures predict survival of early-stage PDAC.
Methods: Serum RNA from archival 15 stage I-III PDAC patients and 4 controls was used for
miRNAs expression profile (Agilent microarrays). PDAC patients with comparable age …
[PDF][PDF] Serum miRNA Profiling for Early PDAC Diagnosis and Prognosis: A Retrospective Study. Biomedicines 2021, 9, 845
A Aita, C Millino, C Sperti, B Pacchioni… - MicroRNA in Solid …, 2021 - mdpi.com
Background: Tumor stage predicts pancreatic cancer (PDAC) prognosis, but prolonged and
short survivals have been described in patients with early-stage tumors. Circulating
microRNA (miRNA) are an emerging class of suitable biomarkers for PDAC prognosis. Our
aim was to identify whether serum miRNA signatures predict survival of early-stage PDAC.
Methods: Serum RNA from archival 15 stage I-III PDAC patients and 4 controls was used for
miRNAs expression profile (Agilent microarrays). PDAC patients with comparable age …
short survivals have been described in patients with early-stage tumors. Circulating
microRNA (miRNA) are an emerging class of suitable biomarkers for PDAC prognosis. Our
aim was to identify whether serum miRNA signatures predict survival of early-stage PDAC.
Methods: Serum RNA from archival 15 stage I-III PDAC patients and 4 controls was used for
miRNAs expression profile (Agilent microarrays). PDAC patients with comparable age …
以上显示的是最相近的搜索结果。 查看全部搜索结果